Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis
Clinical trial NCT06587191 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06587191
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-01
- Primary completion
- 2024-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.